May 2024 - PharmaTimes

May 2024 - PharmaTimes
Published on 24 April 2024

Description:

This month we’re going places and – as our cover so boldly suggests – those places invite parity and equity. Women in pharma is a movement which not only yields a fair and more interesting pharmaverse, it ignites possibilities and propels performance. The edition of PharmaTimes you are about to peruse holds this reality aloft and parades it around our industry. We’ve also got a host of other features which demonstrate the rapid evolution of the life sciences including – the future of pharma, emerging novel therapies, taking on rare diseases and the continuing need to ensure a career in pharma is open to everyone.

Categories:

PharmaTimes
27 articles from this collection:
Cover
Cover
NURSING INDUSTRY EXCELLENCE AWARDS  2024
NURSING INDUSTRY EXCELLENCE AWARDS 2024
From the editor
From the editor
This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration.
Contents
Contents
NEWS: Treatments
NEWS: Treatments
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the potential reclassification of two progestogen-only, oral contraceptive pills containing desogestrel: Lovima 75mcg and Hana 75mcg film-coated tablets.
NEWS: Research
NEWS: Research
NEWS: Collaborations
NEWS: Collaborations
NEWS: Conditions
NEWS: Conditions
WOMEN IN PHARMA - Definitely different
WOMEN IN PHARMA - Definitely different
DIVERSITY: Big rethink
DIVERSITY: Big rethink
SAMEDAN
SAMEDAN
WOMEN IN PHARMA: Alliance of science
WOMEN IN PHARMA: Alliance of science
EQUITY - All things being equal
EQUITY - All things being equal
WOMEN IN PHARMA - Page turners
WOMEN IN PHARMA - Page turners
PARTNERSHIPS: Bridging the gap
PARTNERSHIPS: Bridging the gap
PHARMAROLE
PHARMAROLE
22-24 - FUTURE: The A-Team
22-24 - FUTURE: The A-Team
PHARMATIMES MSEA
PHARMATIMES MSEA
SCIENCE: Reality sights
SCIENCE: Reality sights
28-29 - DATA: Epic grails
28-29 - DATA: Epic grails
CONDITIONS: A new hope
CONDITIONS: A new hope
PATIENTS - New universe
PATIENTS - New universe
CONDITIONS: A licence to kill
CONDITIONS: A licence to kill
Your moves
Your moves
AI – AI together now
AI – AI together now
FLYPHARMA Europe
FLYPHARMA Europe
COMMUNIQUE AWARDS
COMMUNIQUE AWARDS